Evidence map›Paper›PMID 23818983›Full record

ArticlePloS one2013

Application of high-density DNA resequencing microarray for detection and characterization of botulinum neurotoxin-producing clostridia.

Jessica Vanhomwegen, Nicolas Berthet, Christelle Mazuet, Ghislaine Guigon, Tatiana Vallaeys, Rayna Stamboliyska, Philippe Dubois, Giulia C Kennedy, Stewart T Cole, Valérie Caro and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Dual-Toxin-ProducingToxins · 2025
    Article
  2. Article
  3. Article
  4. Frontiers in microbiology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Jessica VanhomwegenInstitut Pasteur, Laboratory for Urgent Responses to Biological Threats, Paris, France.
Nicolas Berthet
Christelle Mazuet
Ghislaine Guigon
Tatiana Vallaeys
Rayna Stamboliyska
Philippe Dubois
Giulia C Kennedy
Stewart T Cole
Valérie Caro
Jean-Claude Manuguerra
Michel-Robert Popoff
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRÉcole Polytechnique Fédérale de Lausanne · CHUrologische Klinik München · DEVeracyte (United States) · US

Funding

Pathogen and Genetic Element Detection Using MicroarraysUC1AI062613 · NIAID · AFFYMETRIX, INC. · PI KENNEDY, GUILIA C · 2004 to 2004
$2.1M
NIAID NIH HHS UC1 AI062613
6 · The paper itself

Abstract

backgroundClostridium botulinum and related clostridia express extremely potent toxins known as botulinum neurotoxins (BoNTs) that cause severe, potentially lethal intoxications in humans. These BoNT-producing bacteria are categorized in seven major toxinotypes (A through G) and several subtypes. The high diversity in nucleotide sequence and genetic organization of the gene cluster encoding the BoNT components poses a great challenge for the screening and characterization of BoNT-producing strains. METHODOLOGY/PRINCIPAL

findingsIn the present study, we designed and evaluated the performances of a resequencing microarray (RMA), the PathogenId v2.0, combined with an automated data approach for the simultaneous detection and characterization of BoNT-producing clostridia. The unique design of the PathogenID v2.0 array allows the simultaneous detection and characterization of 48 sequences targeting the BoNT gene cluster components. This approach allowed successful identification and typing of representative strains of the different toxinotypes and subtypes, as well as the neurotoxin-producing C. botulinum strain in a naturally contaminated food sample. Moreover, the method allowed fine characterization of the different neurotoxin gene cluster components of all studied strains, including genomic regions exhibiting up to 24.65% divergence with the sequences tiled on the arrays. CONCLUSIONS/SIGNIFICANCE: The severity of the disease demands rapid and accurate means for performing risk assessments of BoNT-producing clostridia and for tracing potentials sources of contamination in outbreak situations. The RMA approach constitutes an essential higher echelon component in a diagnostics and surveillance pipeline. In addition, it is an important asset to characterise potential outbreak related strains, but also environment isolates, in order to obtain a better picture of the molecular epidemiology of BoNT-producing clostridia.

Indexed as

Bacterial ProteinsBacterial Typing TechniquesBotulinum ToxinsBotulismClostridium botulinumDNA, BacterialFood ContaminationFood MicrobiologyHumansMultigene FamilyOligonucleotide Array Sequence AnalysisReproducibility of ResultsSensitivity and SpecificitySequence Analysis, DNABacterial ProteinsBotulinum ToxinsDNA, Bacterial

Identifiers

PMID23818983
PMCPMC3688605
OpenAlexW2038330176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.